Five‐year follow‐up of intracoronary autologous cell therapy in acute myocardial infarction: the REGENERATE‐AMI trial

AIMS: The long‐term outcomes of the intracoronary delivery of autologous bone marrow‐derived cells (BMCs) after acute myocardial infarction are not well established. Following the promising 1 year results of the REGENERATE‐AMI trial (despite it not achieving its primary endpoint), this paper present...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathur, Anthony, Sim, Doo Sun, Choudry, Fizzah, Veerapen, Jessry, Colicchia, Martina, Turlejski, Tymoteusz, Hussain, Mohsin, Hamshere, Stephen, Locca, Didier, Rakhit, Roby, Crake, Tom, Kastrup, Jens, Agrawal, Samir, Jones, Daniel A., Martin, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934988/
https://www.ncbi.nlm.nih.gov/pubmed/35043578
http://dx.doi.org/10.1002/ehf2.13786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934988/
https://www.ncbi.nlm.nih.gov/pubmed/35043578
http://dx.doi.org/10.1002/ehf2.13786

Ejemplares similares